{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-003552","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2025-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.316726+00:00","generated_at":"2026-05-24T03:19:36.520740+00:00","sec_items":["1.01","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Dermata raises ~$6.2M via warrant exercise at reduced price; issues new warrants","bullets":["4,834,470 existing warrants exercised at reduced price of $1.284/share, yielding $6.2M gross proceeds.","New Series A warrants (5-year term) and Series B warrants (18-month term) issued, each exercisable at $1.284.","New warrants require shareholder approval per Nasdaq Rule 5635(d); exercise limited to 4.99% (or 9.99%) ownership.","H.C. Wainwright acted as exclusive financial advisor; fees include 7% cash plus 338,412 HCW warrants at $1.605.","Company plans to use net proceeds for general corporate purposes including R&D and clinical trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-003552","json":"https://secwatch.observer/filing/0001654954-25-003552.json","markdown":"https://secwatch.observer/filing/0001654954-25-003552.md","text":"https://secwatch.observer/filing/0001654954-25-003552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425003552/0001654954-25-003552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425003552/drma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:19:36.520740+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}